McLane J Watson

6PUBLICATIONS
64CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursChemical and thermal processes in energy and combustionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 09, 2025
Dietary restriction reprograms CD8+ T cell fate to enhance anti-tumour immunity and immunotherapy responses.

Brandon M Oswald, Lisa M DeCamp, Joseph Longo

|Apr 09, 2025
Mitochondrial fatty acid synthesis and MECR regulate CD4+ T cell function and oxidative metabolism.

KayLee K Steiner, Arissa C Young, Andrew R Patterson

|Aug 16, 2024
ACLY and ACSS2 link nutrient-dependent chromatin accessibility to CD8 T cell effector responses.

Irem Kaymak, McLane J Watson, Brandon M Oswald

|Aug 08, 2023
An oncolytic virus-delivered TGFβ inhibitor overcomes the immunosuppressive tumor microenvironment.

Kristin DePeaux, Dayana B Rivadeneira, Konstantinos Lontos

|Apr 13, 2021
Aberrant CREB1 activation in prostate cancer disrupts normal prostate luminal cell differentiation.

M J Watson, P L Berger, K Banerjee

|Mar 08, 2018
4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses.

Ashley V Menk, Nicole E Scharping, Dayana B Rivadeneira

Pageof 1

Frequent Collaborators

3 joint publications

Ryan D Sheldon

2 joint publications

Russell G Jones

2 joint publications

Greg M Delgoffe

2 joint publications

Kelsey S Williams